Moderna Inc (MRNA)

Fixed asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 3,229,000 5,076,000 5,052,000 5,155,000 6,826,000 9,097,000 10,486,000 14,708,000 18,810,000 20,675,000 22,284,000 21,933,000 17,736,000 11,016,375 6,199,591 2,013,033 274,490 55,668 56,790 38,378
Property, plant and equipment US$ in thousands 2,717,000 2,410,000 2,139,000 2,132,000 1,446,000 1,473,000 1,383,000 960,000 898,000 461,000 387,090 368,593 321,985 302,599
Fixed asset turnover 3.35 4.35 8.79 9.70 15.41 14.89 12.82 11.48 6.90 4.37 0.71 0.15 0.18 0.13

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $3,229,000K ÷ $—K
= —

Fixed asset turnover is a financial ratio that measures a company's efficiency in generating sales from its fixed assets. A higher fixed asset turnover indicates that the company is making more efficient use of its fixed assets to generate revenue.

Analyzing Moderna Inc's fixed asset turnover over the historical period, we observe a significant increase in the ratio, starting from a low of 0.13 in March 2020 to a peak of 15.41 in June 2022. This substantial improvement suggests that Moderna has been able to increase its sales relative to its investment in fixed assets.

However, the ratio experienced a decline in the subsequent periods, dropping to 4.35 in June 2023 and further to 3.35 in September 2023. This decline could indicate that Moderna's sales growth has slowed down relative to its fixed asset base during these periods.

The ratio showed some fluctuation in the later periods, settling at 8.79 in December 2022. The absence of data for the subsequent periods makes it challenging to provide a more current analysis of Moderna's fixed asset turnover.

Overall, the trend in Moderna's fixed asset turnover showcases periods of significant improvement in asset utilization efficiency, followed by some fluctuations and declines. Analyzing this ratio alongside other financial metrics can provide a more comprehensive understanding of the company's operational performance and future prospects.


See also:

Moderna Inc Net Fixed Asset Turnover (Quarterly Data)